SCRAM
Hybrid cell annotation for tumor and non-tumor cells in single-cell datasets, including the identification of hybrid cell states.
The Serin Lab develops AI and single-cell genomic methods to define brain tumor cell states, model therapeutic response, and prioritize clinically actionable interventions. Our long-term goal is to build predictive frameworks that can help make brain tumors treatable with greater precision.
Our research program combines method development with biological and translational questions in neuro-oncology.
Hybrid cell annotation for tumor and non-tumor cells in single-cell datasets, including the identification of hybrid cell states.
Computational annotation of developmental-like cell states in brain tumors using human brain developmental reference atlases.
Integrative cancer subtyping that combines bulk transcriptional measurements with single-cell-derived features and RNA-inferred CNV signals.
Methods for RNA-based genomic profiling, copy-number inference, and expression-linked variant analysis in bulk and single-cell data.
We are especially interested in collaborative projects that connect AI, single-cell genomics, and translational neuro-oncology, as well as students who want to work at that interface.